Bio2040 - Bottlenecks & Future of Science, Healthcare & Biotech

Prof Paul Glasziou is a practitioner and widely published clinical research expert. He explains how we waste billions of dollars on biomedical research.

Over 50% of all health research does not get published at all. From the published research, 50% is not usable in practice because things are missing. And from the 25% which is left, half contains design flaws. Hence, over 87.5% (which they rounded down to 85%) of health research is avoidably wasted according to Glasziou. We explore how this waste happens and what can be done about it.

In Bio2040’s latest episode we had the chance to talk to Sam Lee, a long-time veteran of the biotech space.
This episode covers some of the history and fundamentals of the synthetic biology and biomanufacturing space.

• computer vision and machine learning can be used to do drug discovery
• what the biggest challenges in today's cancer research
• with potential solutions

What are the main challenges in translating scientific innovation from the bench-side to the bedside? Physician and long-term Pharma executive Nadine Martin is now in charge of innovation management at sitem-insel AG. A translational unit of the Inselspital in Bern.